Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status
Marit Tveito, Espen Molden, Gudrun Høiseth, Christoph U Correll, Robert Løvsletten Smith
Bok 2020
| Utgitt | 2020
|
|---|---|
| Omfang | 41-49
|
| Emner |
